Correction to: Efficacy and Safety of Luseogliflozin in Patients with Type 2 Diabetes Complicated by Hepatic Dysfunction: A Single-Site, Single-Arm, Open-Label, Exploratory Trial

被引：0
|
作者：
Hiroaki Seino
机构：
[1] Seino Internal Medical Clinic,
来源：
Diabetes Therapy | 2021年 / 12卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2807 / 2811
页数：4
相关论文
共 50 条
  • [1] Efficacy and Safety of Luseogliflozin in Patients with Type 2 Diabetes Complicated by Hepatic Dysfunction: A Single-Site, Single-Arm, Open-Label, Exploratory Trial
    Seino, Hiroaki
    DIABETES THERAPY, 2021, 12 (03) : 863 - 877
  • [2] Efficacy and Safety of Luseogliflozin in Patients with Type 2 Diabetes Complicated by Hepatic Dysfunction: A Single-Site, Single-Arm, Open-Label, Exploratory Trial
    Hiroaki Seino
    Diabetes Therapy, 2021, 12 : 863 - 877
  • [3] Efficacy and Safety of Luseogliflozin in Patients with Type 2 Diabetes Complicated by Hepatic Dysfunction: A Single-Site, Single-Arm, Open-Label, Exploratory Trial (vol 12, pg 863, 2021)
    Seino, Hiroaki
    DIABETES THERAPY, 2021, 12 (10) : 2807 - 2811
  • [4] Efficacy and safety of minocycline in retinitis pigmentosa: a prospective, open-label, single-arm trial
    Chen, Yuxi
    Pan, Yuan
    Xie, Yanyan
    Shi, Yuxun
    Lu, Yao
    Xia, Yiwen
    Su, Wenru
    Chen, Xiaoqing
    Li, Zuoyi
    Wang, Minzhen
    Miao, Siyu
    Yang, Yating
    Jin, Chenjin
    Luo, Guangwei
    Long, Shixian
    Xiao, Hui
    Huang, Chuangxin
    Zhang, Jian
    Liang, Dan
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [5] Beneficial effects of luseogliflozin on lipid profile and liver function in patients with type 2 diabetes mellitus (BLUE trial): a single-center, single-arm, open-label prospective study
    Yuriko Hajika
    Yuji Kawaguchi
    Kenji Hamazaki
    Yasuro Kumeda
    Diabetology & Metabolic Syndrome, 15
  • [6] Beneficial effects of luseogliflozin on lipid profile and liver function in patients with type 2 diabetes mellitus (BLUE trial): a single-center, single-arm, open-label prospective study
    Hajika, Yuriko
    Kawaguchi, Yuji
    Hamazaki, Kenji
    Kumeda, Yasuro
    DIABETOLOGY & METABOLIC SYNDROME, 2023, 15 (01):
  • [7] Publisher Correction: Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis
    Priscilla K. Brastianos
    Eudocia Quant Lee
    Justine V. Cohen
    Sara M. Tolaney
    Nancy U. Lin
    Nancy Wang
    Ugonma Chukwueke
    Michael D. White
    Naema Nayyar
    Albert Kim
    Christopher Alvarez-Breckenridge
    Ian Krop
    Maura Keeley Mahar
    Mia S. Bertalan
    Brian Shaw
    Joana L. Mora
    Nathaniel Goss
    Megha Subramanian
    Lakshmi Nayak
    Jorg Dietrich
    Deborah A. Forst
    Brian V. Nahed
    Tracy T. Batchelor
    Helen A. Shih
    Elizabeth R. Gerstner
    Beverly Moy
    Donald Lawrence
    Anita Giobbie-Hurder
    Scott L. Carter
    Kevin Oh
    Daniel P. Cahill
    Ryan J. Sullivan
    Nature Medicine, 2020, 26 : 1309 - 1309
  • [8] Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis
    Brastianos, Priscilla K.
    Lee, Eudocia Quant
    Cohen, Justine V.
    Tolaney, Sara M.
    Lin, Nancy U.
    Wang, Nancy
    Chukwueke, Ugonma
    White, Michael D.
    Nayyar, Naema
    Kim, Albert
    Alvarez-Breckenridge, Christopher
    Krop, Ian
    Mahar, Maura Keeley
    Bertalan, Mia S.
    Shaw, Brian
    Mora, Joana L.
    Goss, Nathaniel
    Subramanian, Megha
    Nayak, Lakshmi
    Dietrich, Jorg
    Forst, Deborah A.
    Nahed, Brian V.
    Batchelor, Tracy T.
    Shih, Helen A.
    Gerstner, Elizabeth R.
    Moy, Beverly
    Lawrence, Donald
    Giobbie-Hurder, Anita
    Carter, Scott L.
    Oh, Kevin
    Cahill, Daniel P.
    Sullivan, Ryan J.
    NATURE MEDICINE, 2020, 26 (08) : 1280 - +
  • [9] Efficacy and Safety of Tracnil™ Administration in Patients with Dermatological Manifestations of PCOS: An Open-Label Single-Arm Study
    Ramanan, Ezhil Arasan
    Ravi, Sailatha
    Anbu, K. R. Radha
    Michael, Margaret
    DERMATOLOGY RESEARCH AND PRACTICE, 2020, 2020
  • [10] Evaluation of efficacy and safety of Lascufloxacin tablet for Nursing and healthcareassociated pneumonia: Single-arm, open-label clinical trial
    Hosogaya, Naoki
    Takazono, Takahiro
    Ota, Kenji
    Ito, Yuta
    Ashizawa, Nobuyuki
    Takeda, Kazuaki
    Iwanaga, Naoki
    Yoshino, Yukari
    Ishikawa, Yasuyuki
    Izumikawa, Koichi
    Yatera, Kazuhiro
    Yanagihara, Katsunori
    Mukae, Hiroshi
    RESPIROLOGY, 2023, 28 : 204 - 205
12345